DUNAD THERAPEUTICS LTD.

Company number 12544797

Date	Type	Description	View / Download
07 May 2021	CS01	Confirmation statement made on 1 April 2021 with updates	(4 pages)
29 Jan 2021	CH01	Director's details changed for Dziyana Kraskouskaya on 1 August 2020	(2 pages)
29 Jan 2021	PSC04	Change of details for Dziyana Kraskouskaya as a person with significant control on 27 November 2020	(2 pages)
29 Jan 2021	MA	Memorandum and Articles of Association	(54 pages)
08 Dec 2020	RESOLUTIONS	Resolutions RES01 ‐ Resolution of alteration of Articles of Association	(1 page)
08 Dec 2020	RESOLUTIONS	Resolutions RES01 ‐ Resolution of alteration of Articles of Association	(1 page)
30 Nov 2020	SH01	Statement of capital following an allotment of shares on 27 November 2020 GBP 1,000.001	(3 pages)
15 Sep 2020	AD01	Registered office address changed from 15th Floor 125 Old Broad Street London EC2N 1AR United Kingdom to 30 Broad Street Great Cambourne Cambridge CB23 6HJ on 15 September 2020	(1 page)
14 Aug 2020	RESOLUTIONS	Resolutions NM01 ‐ Change of name by resolution RES15 ‐ Change company name resolution on 2020-08-05	(3 pages)
29 Apr 2020	MA	Memorandum and Articles of Association	(54 pages)
29 Apr 2020	RESOLUTIONS	Resolutions RES12 ‐ Resolution of varying share rights or name RES01 ‐ Resolution of adoption of Articles of Association	(1 page)
28 Apr 2020	SH10	Particulars of variation of rights attached to shares	(2 pages)
28 Apr 2020	SH08	Change of share class name or designation	(2 pages)
22 Apr 2020	PSC04	Change of details for Dziyana Kraskouskaya as a person with significant control on 22 April 2020	(2 pages)
22 Apr 2020	PSC02	Notification of Epidarex Capital Iii Uk, Lp as a person with significant control on 22 April 2020	(2 pages)
22 Apr 2020	AP01	Appointment of Dr Elizabeth Ann Roper as a director on 22 April 2020	(2 pages)
22 Apr 2020	SH01	Statement of capital following an allotment of shares on 22 April 2020 GBP 600.001	(3 pages)
21 Apr 2020	AP01	Appointment of Dziyana Kraskouskaya as a director on 20 April 2020	(2 pages)
20 Apr 2020	TM01	Termination of appointment of Vanessa Lea Mcminn as a director on 20 April 2020	(1 page)
20 Apr 2020	AA01	Current accounting period extended from 30 April 2021 to 31 August 2021	(1 page)
20 Apr 2020	PSC07	Cessation of Vanessa Lea Mcminn as a person with significant control on 20 April 2020	(1 page)
20 Apr 2020	PSC01	Notification of Dziyana Kraskouskaya as a person with significant control on 20 April 2020	(2 pages)
02 Apr 2020	NEWINC	Incorporation MODEL ARTICLES ‐ Model articles adopted (Amended Provisions) Statement of capital on 2020-04-02 GBP .001	(27 pages)

Previous

• 1
• 2
• 3
• 4